Published in J Psychiatr Res on February 21, 2010
Translational PK-PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. Psychopharmacology (Berl) (2011) 0.80
Doxepin concentrations in plasma and cerebrospinal fluid. J Neural Transm (Vienna) (2011) 0.77
The effect of quetiapine (Seroquel™) on conditioned place preference and elevated plus maze tests in rats when administered alone and in combination with (+)-amphetamine. Psychopharmacology (Berl) (2014) 0.76
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int J Neuropsychopharmacol (2007) 2.60
Effectiveness of neonatal pulse oximetry screening for detection of critical congenital heart disease in daily clinical routine--results from a prospective multicenter study. Eur J Pediatr (2010) 2.18
Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet (2002) 1.96
L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors. Proc Natl Acad Sci U S A (2013) 1.94
Normobaric hyperoxia--induced improvement in cerebral metabolism and reduction in intracranial pressure in patients with severe head injury: a prospective historical cohort-matched study. J Neurosurg (2004) 1.80
Mechanical thromboembolectomy for acute ischemic stroke: comparison of the catch thrombectomy device and the Merci Retriever in vivo. Stroke (2008) 1.64
High brain lactate is a hallmark of aging and caused by a shift in the lactate dehydrogenase A/B ratio. Proc Natl Acad Sci U S A (2010) 1.52
The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease. Arch Neurol (2010) 1.46
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment. Clin Pharmacol Ther (2005) 1.45
Multicenter study on the clinical effectiveness, pharmacokinetics, and pharmacogenetics of mirtazapine in depression. J Clin Psychopharmacol (2012) 1.44
Modulation of event-related brain potentials during affective picture processing: a complement to startle reflex and skin conductance response? Int J Psychophysiol (2004) 1.44
The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev (2005) 1.43
Dose effects and image quality: is there any influence by bearing devices in whole-body computed tomography in trauma patients? Injury (2013) 1.43
From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res Rev (2007) 1.42
Call for uniform neuropsychological assessment after aneurysmal subarachnoid hemorrhage: Swiss recommendations. Acta Neurochir (Wien) (2015) 1.40
The antidepressant effect of running is associated with increased hippocampal cell proliferation. Int J Neuropsychopharmacol (2005) 1.36
Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol (2002) 1.35
Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc. Appl Radiat Isot (2012) 1.31
The role of 5-HT(1A) receptors in learning and memory. Behav Brain Res (2008) 1.28
The EDNAP mitochondrial DNA population database (EMPOP) collaborative exercises: organisation, results and perspectives. Forensic Sci Int (2004) 1.26
Running is rewarding and antidepressive. Physiol Behav (2007) 1.25
Autologous stem cell transplantation for systemic lupus erythematosus. Lupus (2004) 1.24
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder. Neuropsychopharmacology (2011) 1.21
High opiate receptor binding potential in the human lateral pain system. Neuroimage (2005) 1.20
Understanding resilience. Front Behav Neurosci (2013) 1.19
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. Eur Neuropsychopharmacol (2009) 1.19
Parametric mapping of binding in human brain of D2 receptor ligands of different affinities. J Nucl Med (2005) 1.15
Quetiapine affects neuropeptide Y and corticotropin-releasing hormone in cerebrospinal fluid from schizophrenia patients: relationship to depression and anxiety symptoms and to treatment response. Int J Neuropsychopharmacol (2011) 1.14
Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol (2007) 1.10
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons. Proc Natl Acad Sci U S A (2013) 1.09
Correspondence (letter to the editor): Paradigm shift. Dtsch Arztebl Int (2013) 1.07
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients. Eur J Clin Pharmacol (2005) 1.06
Spinal cerebrospinal fluid leak as the cause of chronic subdural hematomas in nongeriatric patients. J Neurosurg (2014) 1.03
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine. J Clin Psychopharmacol (2009) 1.03
High-sensitive liquid chromatographic method for determination of neuronal release of serotonin, noradrenaline and dopamine monitored by microdialysis in the rat prefrontal cortex. J Neurosci Methods (2004) 1.03
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides (2006) 1.03
Antidepressant treatment is associated with epigenetic alterations in the promoter of P11 in a genetic model of depression. Int J Neuropsychopharmacol (2011) 1.03
Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity. Eur J Clin Pharmacol (2004) 1.03
Chronic multifocal non-bacterial osteomyelitis in hypophosphatasia mimicking malignancy. BMC Pediatr (2007) 1.02
Lithium treatment alters brain concentrations of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor in a rat model of depression. Int J Neuropsychopharmacol (2003) 1.02
Neuropeptide expression in rats exposed to chronic mild stresses. Psychopharmacology (Berl) (2004) 1.02
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain. Eur Neuropsychopharmacol (2007) 1.01
Effect of age and gender on citalopram and desmethylcitalopram steady-state plasma concentrations in adults and elderly depressed patients. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.01
Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening. Addict Behav (2005) 1.01
Effects of levothyroxine on bone mineral density, muscle force, and bone turnover markers: a cohort study. J Clin Endocrinol Metab (2012) 1.01
The influence of baseline symptoms and insight on the therapeutic alliance early in the treatment of schizophrenia. Eur Psychiatry (2009) 1.00
Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study. Pharmacol Res (2008) 0.99
Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides (2005) 0.99
Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int J Neuropsychopharmacol (2009) 0.99
Central functions of neuropeptide Y in mood and anxiety disorders. Expert Opin Ther Targets (2011) 0.99
Phylo- and ontogenetic fears and the expectation of danger: differences between spider- and flight-phobic subjects in cognitive and physiological responses to disorder-specific stimuli. J Abnorm Psychol (2006) 0.98
Development of an HPLC-PAD-MS assay for the identification and quantification of major phenolic edelweiss (Leontopodium alpium Cass.) constituents. Phytochem Anal (2006) 0.98
Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response. Psychopharmacology (Berl) (2005) 0.98
Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology (2002) 0.97
Resting glutamate levels and rapid glutamate transients in the prefrontal cortex of the Flinders Sensitive Line rat: a genetic rodent model of depression. Neuropsychopharmacology (2011) 0.97
Concurrent monitoring of cerebral electrophysiology and metabolism after traumatic brain injury: an experimental and clinical study. J Neurotrauma (2005) 0.96
Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol (2006) 0.96
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizers. J Clin Psychopharmacol (2002) 0.96
Virtual reality for the psychophysiological assessment of phobic fear: responses during virtual tunnel driving. Psychol Assess (2007) 0.95
The precuneus and the insula in self-attributional processes. Cogn Affect Behav Neurosci (2013) 0.95
Quantitative real-time reverse-transcription polymerase chain reaction for diagnosis of BCR-ABL positive leukemias and molecular monitoring following allogeneic stem cell transplantation. Eur J Haematol (2003) 0.95
Running has differential effects on NPY, opiates, and cell proliferation in an animal model of depression and controls. Neuropsychopharmacology (2006) 0.95
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95
The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus (2010) 0.95
Effects of prolonged ethanol vapor exposure on forced swim behavior, and neuropeptide Y and corticotropin-releasing factor levels in rat brains. Alcohol (2010) 0.94
Theory relating in vitro and in vivo microdialysis with one or two probes. J Neurochem (2002) 0.94
Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride. J Nucl Med (2003) 0.93
SPECT-CT image fusion could enhance Meckel scan. World J Pediatr (2010) 0.93
Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study. Int J Nanomedicine (2011) 0.93
Cerebral acid-base homeostasis after severe traumatic brain injury. J Neurosurg (2005) 0.93
Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.93
Case 150: Van Buchem disease (hyperostosis corticalis generalisata). Radiology (2009) 0.92
Social support in bipolar disorder: its relevance to remission and relapse. Bipolar Disord (2003) 0.92
Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study. Schizophr Bull (2011) 0.92
Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD). J Neurol (2002) 0.92
Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram. Int J Neuropsychopharmacol (2005) 0.92
Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res (2004) 0.91
Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone. Clin Pharmacol Ther (2004) 0.91
Remodelling by early-life stress of NMDA receptor-dependent synaptic plasticity in a gene-environment rat model of depression. Int J Neuropsychopharmacol (2008) 0.91
Radioiodine therapy of thyroid autonomy. Eur J Nucl Med Mol Imaging (2002) 0.90
A contoured locking plate for distal fibular fractures in osteoporotic bone: a biomechanical cadaver study. Injury (2011) 0.90
Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.90
A novel method for analyzing DSCE-images with an application to tumor grading. Invest Radiol (2008) 0.90
Effect of laser soldering irradiation on covalent bonds of pure collagen. Lasers Med Sci (2006) 0.90
Radiation exposure in whole-body computed tomography of multiple trauma patients: bearing devices and patient positioning. Injury (2011) 0.89
Serum levels of aripiprazole and dehydroaripiprazole, clinical response and side effects. World J Biol Psychiatry (2008) 0.89
Enhanced hippocampal noradrenaline and serotonin release in galanin-overexpressing mice after repeated forced swimming test. Proc Natl Acad Sci U S A (2003) 0.89
SIRT was given short shrift. Dtsch Arztebl Int (2014) 0.89
Richard von Volkmann: surgeon and Renaissance man. Clin Orthop Relat Res (2008) 0.89
Acute blood pressure effects and chronic hypotensive action of calcimimetics in uremic rats. J Am Soc Nephrol (2006) 0.88
Effect of protein-energy malnutrition in early life on the dimensions and bone quality of the adult rat mandible. Arch Oral Biol (2002) 0.88
Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects. Eur J Clin Pharmacol (2004) 0.88
Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene. J Clin Psychopharmacol (2004) 0.88
Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses. Drug Alcohol Depend (2003) 0.88
Protection but maintained dysfunction of nigral dopaminergic nerve cell bodies and striatal dopaminergic terminals in MPTP-lesioned mice after acute treatment with the mGluR5 antagonist MPEP. Brain Res (2005) 0.88